Human milk oligosaccharides shape small intestinal microbiota and epithelial transcriptional profile during early

Zhongxin Li1,2, Yuxi Shen1,2, Wen Wang1,2

  • 1School of Food Science and Engineering, Overseas Expertise Introduction Center for Discipline Innovation of Food Nutrition and Human Health, South China University of Technology, Guangzhou 510640, China. zhangb@scut.edu.cn.

Food & Function
|May 1, 2026
PubMed

Human milk oligosaccharides (HMOs) are important mediators of infant colonic microbiota and host immunity, yet their region-specific effects on the small intestine remain poorly characterized. To address this, this study established an intervention model using C57BL/6J neonatal mice, in which two HMOs, namely 2'-fucosyllactose (2'FL) and lacto-N-neotetraose (LNnT), were administered daily by oral gavage from postnatal day 7 to day 28. The results showed that both HMOs enhanced systemic anti-inflammatory capacity without affecting pup growth performance. Subsequently, multi-omics analysis of the small intestine in pups revealed that 2'FL activated innate immune pathways and upregulated the expression of genes related to immunomodulation, inflammation, and intestinal barrier function, while also reducing potentially harmful bacteria (e.g., Streptococcus) and enhancing beneficial bacteria (e.g., Ligilactobacillus), with concurrent elevation of anti-inflammatory metabolites such as glycoursodeoxycholic acid and sebacic acid. Interestingly, LNnT activated adaptive immune pathways and elevated the expression of genes involved in immune system development and differentiation, B-cell and T-cell lineage specification, as well as immunoregulation, while reducing harmful bacteria (e.g., Desulfovibrio) and enhancing beneficial bacteria (e.g., Lachnoclostridium), along with increased immunomodulatory metabolites such as tricin and baicalein. Correlation network analysis revealed HMO-specific small intestinal "microbiota-metabolite-immune" axes, wherein microbial changes were strongly associated with metabolite profiles, which in turn correlated with the expression of small intestinal immune-related genes as well as serum inflammatory cytokines. This study demonstrates that HMOs can modulate the small intestinal microbiota and epithelial transcription in a structure-specific manner in pups.

Related Concept Videos

Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
61
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
65.2K
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
65
Microbiota of the Stomach and Small Intestine01:27

Microbiota of the Stomach and Small Intestine

The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...
77
Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity,...
209
Microbiota of the Large Intestine01:27

Microbiota of the Large Intestine

The large intestine hosts the most densely populated microbial ecosystem in the human body. This complex community primarily consists of anaerobic bacteria, with Bacillota (formerly Firmicutes) and Bacteroidota (formerly Bacteroidetes) as the predominant groups. The distribution of these microbes varies along different sections of the large intestine, influenced by local environmental factors such as oxygen availability and nutrient composition.The cecum, located at the beginning of the large...
98